Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.66 |
| ▸ | PPARA | Q07869 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.54 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.54 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.54 |
| ▸ | IAPP | P10997 | 1/20 | 0.52 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | GMNN | O75496 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9651410 | 0.89 | KAT8 (0.73) | KAT8PPARACYP1A2CYP3A4CYP2C9 | |
| SCHEMBL15060630 | 0.86 | KAT8 (0.69) | KAT8PPARACYP3A4TRPV1HSD17B10 | |
| SCHEMBL28252921 | 0.86 | KAT8 (0.73) | KAT8PPARACYP1A2CYP3A4CYP2C9 | |
| SCHEMBL8392909 | 0.84 | KAT8 (0.70) | KAT8PPARACYP1A2CYP3A4CYP2C9 | |
| SCHEMBL29093731 | 0.82 | KAT8 (0.63) | KAT8PPARATRPV1HSD17B10MAPT | |
| SCHEMBL28445615 | 0.81 | KAT8 (0.79) | KAT8PPARACYP1A2CYP3A4CYP2C9 | |
| SCHEMBL10826047 | 0.80 | IAPP (0.79) | KAT8PPARACYP1A2CYP3A4CYP2C9 | |
| SCHEMBL2529442 | 0.80 | KAT8 (1.00) | KAT8PPARA | |
| SCHEMBL1373683 | 0.80 | KAT8 (1.00) | KAT8PPARA | |
| SCHEMBL8531761 | 0.80 | KAT8 (0.77) | KAT8PPARACYP3A4IAPPTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140264166-A1 | PHENOXYPYRAZOLE COMPOSITION AND PROCESS FOR THE SOLVENT EXTRACTION OF METALS | CYTEC TECHNOLOGY CORP. (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140264166-A1 | PHENOXYPYRAZOLE COMPOSITION AND PROCESS FOR THE SOLVENT EXTRACTION OF METALS | CYTEC TECHNOLOGY CORP. (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140264166-A1 | PHENOXYPYRAZOLE COMPOSITION AND PROCESS FOR THE SOLVENT EXTRACTION OF METALS | CYTEC TECHNOLOGY CORP. (US) | 2014-09-18 | — | — | US | disclosed |
| US-20130264519-A1 | Phenoxypyrazole Composition and Process for the Solvent Extraction of Metals | CYTEC TECHNOLOGY CORP. | 2013-10-10 | — | — | US | disclosed |
| US-20130264519-A1 | Phenoxypyrazole Composition and Process for the Solvent Extraction of Metals | CYTEC TECHNOLOGY CORP. | 2013-10-10 | — | — | US | disclosed |
| US-20130264519-A1 | Phenoxypyrazole Composition and Process for the Solvent Extraction of Metals | CYTEC TECHNOLOGY CORP. | 2013-10-10 | — | — | US | disclosed |
| US-8470052-B2 | Phenoxypyrazole composition and process for the solvent extraction of metals | CYTEC TECHNOLOGY CORP. (US) | 2013-06-25 | — | — | US | disclosed |
| US-8470052-B2 | Phenoxypyrazole composition and process for the solvent extraction of metals | CYTEC TECHNOLOGY CORP. (US) | 2013-06-25 | — | — | US | disclosed |
| EP-1926713-B1 | PROCESS FOR THE SOLVENT EXTRACTION OF METALS | CYTEC TECH CORP (US) | 2013-04-10 | — | — | EP | disclosed |
| US-20120118109-A1 | PHENOXYPYRAZOLE COMPOSITION AND PROCESS FOR THE SOLVENT EXTRACTION OF METALS | CYTEC TECHNOLOGY CORP. (US) | 2012-05-17 | — | — | US | disclosed |
| US-20120118109-A1 | PHENOXYPYRAZOLE COMPOSITION AND PROCESS FOR THE SOLVENT EXTRACTION OF METALS | CYTEC TECHNOLOGY CORP. (US) | 2012-05-17 | — | — | US | disclosed |
| US-8088810-B2 | Phenoxypyrazole composition and process for the solvent extraction of metals | CYTEC TECHNOLOGY CORP. (US) | 2012-01-03 | — | — | US | disclosed |
| US-8088810-B2 | Phenoxypyrazole composition and process for the solvent extraction of metals | CYTEC TECHNOLOGY CORP. (US) | 2012-01-03 | — | — | US | disclosed |
| US-20080312452-A1 | Phenoxypyrazole Composition and Process for the Solvent Extraction of Metals | CYTEC TECHNOLOGY CORP. | 2008-12-18 | — | — | US | disclosed |
| US-20080312452-A1 | Phenoxypyrazole Composition and Process for the Solvent Extraction of Metals | CYTEC TECHNOLOGY CORP. | 2008-12-18 | — | — | US | disclosed |
| EP-1926713-A1 | PHENOXYPYRAZOLE COMPOSITION AND PROCESS FOR THE SOLVENT EXTRACTION OF METALS | CYTEC TECHNOLOGY CORP. (US) | 2008-06-04 | — | — | EP | disclosed |
| WO-2007040817-A1 | PHENOXYPYRAZOLE COMPOSITION AND PROCESS FOR THE SOLVENT EXTRACTION OF METALS | CYTEC TECHNOLOGY CORP. (US) | 2007-04-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080312452-A1 | Phenoxypyrazole Composition and Process for the Solvent Extraction of Metals | PRMT9, CHD9, CYP2C9 | KAT8 323/4885PPARA 2110/4885CYP1A2 98/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.